Literature DB >> 8565771

Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults.

T Valdimarsson1, L Franzen, E Grodzinsky, T Skogh, M Ström.   

Abstract

The comparative diagnostic value of IgA anti-endomysium and IgA antigliadin antibodies in adults with histologically confirmed celiac disease is reported. Sera from 144 adult patients (without concurrent dermatitis herpetiformis or IgA deficiency) who underwent small bowel biopsy were analyzed for both IgA anti-endomysium and IgA anti-gliadin antibodies. Nineteen patients (13%) had celiac disease. The presence of IgA antiendomysium antibodies had a sensitivity of 74% and a specificity of 100%. The positive and negative predictive values were 100% and 96%, respectively, and the diagnostic accuracy was 97%. In contrast, IgA anti-gliadin antibodies had positive and negative predictive values of 28% and 96%, respectively, with a diagnostic accuracy of 71%. Based on these data, we suggest that small bowel biopsy is not necessary to diagnose celiac disease in symptomatic adults with IgA antiendomysium antibodies. Due to a negative predictive value of 96%, some symptomatic adults lacking anti-endomysium antibodies will not be correctly diagnosed without small bowel biopsy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565771     DOI: 10.1007/bf02208588

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions.

Authors:  C P Kelly; C F Feighery; R B Gallagher; M J Gibney; D G Weir
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  IgA antiendomysial antibody test. A step forward in celiac disease screening.

Authors:  U Volta; N Molinaro; M Fusconi; F Cassani; F B Bianchi
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies.

Authors:  E Grodzinsky; L Franzen; J Hed; M Ström
Journal:  Ann Allergy       Date:  1992-07

4.  Endomysial versus gliadin antibodies in diagnosis of coeliac disease in short children with no gastrointestinal symptoms.

Authors:  E Cacciari; S Salardi; S Tiberi; U Volta; N Molinaro; F B Bianchi; G F Bottazzo
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

5.  Serological markers and celiac disease: a new diagnostic approach?

Authors:  M Calabuig; R Torregosa; P Polo; L Tuset; C Tomás; V Alvarez; A Garcia-Vila; J Brines; P Vilar; C Farré
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-05       Impact factor: 2.839

6.  IgG endomysial antibodies in IgA-deficient patient with coeliac disease.

Authors:  E H Beutner; V Kumar; T P Chorzelski; M Szaflarska-Czerwionka
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

7.  Evaluation of gliadin antibodies for detection of coeliac disease.

Authors:  A F Kilander; G Dotevall; S P Fällström; R E Gillberg; L A Nilsson; A Tarkowski
Journal:  Scand J Gastroenterol       Date:  1983-05       Impact factor: 2.423

8.  Screening for coeliac disease in adults by simultaneous determination of IgA and IgG gliadin antibodies.

Authors:  S U Friis; E Gudmand-Høyer
Journal:  Scand J Gastroenterol       Date:  1986-11       Impact factor: 2.423

9.  Endomysial antibody: is it the best screening test for coeliac disease?

Authors:  M Ferreira; S L Davies; M Butler; D Scott; M Clark; P Kumar
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

10.  IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients.

Authors:  E Grodzinsky; J Hed; T Skogh
Journal:  Allergy       Date:  1994-09       Impact factor: 13.146

View more
  23 in total

1.  Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study.

Authors:  J A Murray; J Herlein; F Mitros; J A Goeken
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 2.  Endomysial antibody in the diagnosis and management of coeliac disease.

Authors:  M W James; B B Scott
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

3.  Diagnostic approach to a patient with suspected celiac disease: a cost analysis.

Authors:  G C Harewood; J A Murray
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

4.  Anti-endomysial antibody negative celiac disease: does additional serological testing help?

Authors:  A Dahele; K Kingstone; J Bode; D Anderson; S Ghosh
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

5.  Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing.

Authors:  H E Prince; G L Norman; W L Binder
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

6.  Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides.

Authors:  Harry E Prince
Journal:  Clin Vaccine Immunol       Date:  2006-01

7.  Screening for celiac disease in family members: is follow-up testing necessary?

Authors:  David Goldberg; Debbie Kryszak; Alessio Fasano; Peter H R Green
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

Review 8.  Malabsorption testing: a review.

Authors:  P M Ginsburg; P Janefalkar; D T Rubin; E D Ehrenpreis
Journal:  Curr Gastroenterol Rep       Date:  2000-10

Review 9.  Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity.

Authors:  David Armstrong; Andrew C Don-Wauchope; Elena F Verdu
Journal:  Can J Gastroenterol       Date:  2011-04       Impact factor: 3.522

10.  A zebra is not always a zebra and a zero is not always a zero.

Authors:  I Krantz; P Nordin; H Wedel; S Blomstrand; H Ascher
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.